• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HVN
Click for more information
0.43% $4.66

HARVEY NORMAN HOLDINGS LIMITED - Charts / Financials

Market Cap $5.825B  ! watchlist Created with Sketch. Add to my watchlist
Consumer Cyclical Department Stores

Harvey Norman Holdings Limited is an Australia-based company engaged in the integrated... Harvey Norman Holdings Limited is an Australia-based company engaged in the integrated retail, franchise, property and digital system business. Its principal activities include franchisor; sale of furniture, bedding, computers, communications and consumer electrical products in New Zealand, Singapore, Malaysia, Slovenia, Ireland, Northern Ireland and Croatia; property investment; lessor of premises to Harvey Norman, Domayne and Joyce Mayne franchisees and other third parties; media placement, and provision of consumer finance and other commercial loans and advances. Its segments include Franchising Operations, Retail-New Zealand, Retail-Singapore & Malaysia, Retail-Slovenia & Croatia, Retail-Ireland & Northern Ireland, Other Non-Franchised Retail, Retail Property, Retail Property Under Construction, Property Developments for Resale, Equity Investments, and Other. Its brands sell products under various categories, including electrical goods, furniture, and computerized communications.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 16/01/2025 (20 minute delay) ?
Day
Open $4.69   Day High $4.72   Day Low $4.66
Daily Volume 963837
Bids   Sellers
Number Price Volume   Number Price Volume
8 $4.66 73230   1 $4.67 2019

Directors & Senior Management

Mr. Gerald Harvey Executive Chairman of the Board
Ms. Kay Lesley Page Chief Executive Officer, Executive Director
Mr. Chris Mentis Chief Financial Officer, Company Secretary, Executive Director
Mr. John Evyn Slack-Smith Chief Operating Officer, Executive Director
Mr. Gordon Ian Dingwall Chief Information Officer
Mr. Christopher Coen General Manager - Home Appliances
Mr. Benjamin Kelada General Manager - Audio Visual
Ms. Carene Myers General Manager - Small Appliances
Mr. Haydon Ian Myers General Manager - Electrical
Mr. Darren Salakas General Manager - Technology & Entertainment
Mr. Christopher Herbert Brown Non-Executive Director
Mr. Michael John Harvey Non-Executive Director
Ms. Luisa Catanzaro Non-Executive Independent Director
Mr. Maurice John Craven Non-Executive Independent Director
Mr. Kenneth William Gunderson Briggs Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$4.66 		Change
0.020(0.43%) 		Mkt cap ! $5.825B
Open High Low Value Volume
$4.69 $4.72 $4.66 $4.500M 963.8K

Buyers (Bids)

No. Vol. Price($)
8 73230 $4.66
 

Sellers (Offers)

Price($) Vol. No.
$4.67 2019 1
View Market Depth
Last trade - 16.10pm 16/01/2025 (20 minute delay) ?
Last
$4.66 		  Change
0.020 ( 0.49 %)
Open High Low Volume
$4.70 $4.72 $4.66 184910
Last updated 15.59pm 16/01/2025 ?

Top Stories

HotCopper Highlights: Your most watched stocks for Week 2, 2025

Welcome back! It's 2025, and traders are looking for stockpicking opportunities. Here's what HotCopper users are watching.
Week 2 Wrap: Insignia denies Brookfield bid; Star teetering; 1.5C breached & Samsung’s AI TVs It's been a strange week, and it's the first of the year (sort of.) Exxon's suing Twiggy; Samsung's got AI TVs. Then there's climate change.
Southern Cross Gold Consolidated's January 'IPO' is all a bit confusing. Here's what happened Southern Cross Gold Consolidated will be ringing the bell on the ASX today at 3PM in Sydney, and while it is listed as a float, it’s a little more complicated than that @ today’s IPO is really arriving on a deferred settlement basis.In the simplest sense, this is a...
Dimerix signs up first patient for 'highly significant' paediatric clinical trial Dimerix Limited (ASX:DXB), a Melbourne-based biopharmaceutical company, has started recruitment for its first paediatric patient for the Phase 3 ACTION3 clinical trial in a major next step for the research.The trial will investigate the efficacy of DMX-200 in children aged 12 to 17 with focal seg...
Tabcorp up more than 5% after appointing 'one of the world's most sought-after wagering executives' Tabcorp Holdings Ltd has seen its share price rise after announcing the appointment of top wagering executive Michael Fitzsimons
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.